HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The new topical steroid ciclesonide is effective in the treatment of allergic rhinitis.

Abstract
A randomized, placebo-controlled, double-blind crossover study was performed to investigate the efficacy of ciclesonide nasal spray in allergic rhinitis at the dose level of 200 micrograms per nostril. Twenty-four subjects (13 males, 11 females; median age: 28 years) with a history of allergic rhinitis but free of symptoms at screening entered the study. Ciclesonide and placebo were given for 7 days each with a washout period of at least 14 days in between. In both treatment periods, controlled intranasal allergen provocation with pollen extracts was performed on the 2 days before start of treatment (days -2 and -1) and on all treatment days (days 1 to 7) about 2 hours after administration of the study medication. At 5 and 30 minutes after each allergen provocation, rhinal airflow was measured by anterior rhinomanometry, and the subjective symptoms of obstruction, itching, and rhinorrhea were assessed by means of a standardized visual analog scale. Rhinal airflow improved significantly from day 5, while the subjective symptom of obstruction improved from day 2. Itching and rhinorrhea also improved significantly. The local and systemic tolerability of ciclesonide nasal spray was excellent. The results of this study clearly indicate that the new topical steroid ciclesonide is effective in the treatment of allergic rhinitis without producing local or systemic side effects.
AuthorsB M Schmidt, W Timmer, A C Georgens, M Hilt, C Mattinger, W Wurst, K Hörmann, M Wehling
JournalJournal of clinical pharmacology (J Clin Pharmacol) Vol. 39 Issue 10 Pg. 1062-9 (Oct 1999) ISSN: 0091-2700 [Print] England
PMID10516941 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Allergens
  • Anti-Inflammatory Agents
  • Pregnenediones
  • ciclesonide
Topics
  • Administration, Intranasal
  • Adolescent
  • Adult
  • Allergens (adverse effects)
  • Anti-Inflammatory Agents (therapeutic use)
  • Cross-Over Studies
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nasal Mucosa (drug effects, metabolism)
  • Nasal Obstruction (chemically induced, prevention & control)
  • Nasal Provocation Tests
  • Pregnenediones (therapeutic use)
  • Pruritus (chemically induced, prevention & control)
  • Rhinitis (drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: